Evidence-Based Complementary and Alternative Medicine / 2013 / Article / Tab 1 / Review Article
Chinese Medicine Injection Shuanghuanglian for Treatment of Acute Upper Respiratory Tract Infection: A Systematic Review of Randomized Controlled Trials Table 1 Characteristics of included studies.
Study ID Number (male/female) Treatment/control Disease SHL intravenous injection, dosage Treatment duration Control Outcome measure Li 1996 [23 ] 103/67 86/84 Acute tonsillitis 60 mg/kg/d (injection powder) 3 d Penicillin Fever resolution
Li and Jia 2000 [24 ] 35/53 50/38 Acute upper respiratory infection 1 mL/kg/d (injection) 3 d Ribavirin and lincomycin Fever resolution after treatment; time to resolution of fever Li 2002 [25 ] 53/42 48/47 Acute tonsillitis 60 mg/kg/d (injection powder) 5 d Penicillin Fever resolution
Hong et al. 2003 [22 ] 73/50 62/61 Acute tonsillitis 60 mg/kg/d 5 d Penicillin Fever resolution
Zhang and Hu 2003 [27 ] 45/37 52/30 Acute upper respiratory infection 1 mL/kg/d, 20 mL (maximum) (injection) 3–7 d Penicillin and ribavirin No clear description Liang 2007 [26 ] 54/36 49/41 Acute upper respiratory infection 60 mg/kg/d (injection powder) 5 d Ribavirin Fever resolution
Gao and Xu 2010 [21 ] 77/53 68/62 Acute upper respiratory infection 60 mg/kg/d (injection powder) 5 d Ribavirin Fever resolution after treatment; time to resolution of fever, cough, and nasal congestion and discharge
Cui et al. 2012 [20 ] 57/22 41/38 Acute upper respiratory infection 60 mg/kg/d (injection powder) 5 d Ribavirin Fever resolution after treatment; time to resolution of fever, cough, and sore throat